AXSM vs MMC · rev $409.6M vs P/E 22, rev $26.98B
Axsome Therapeutics Inc (AXSM) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported MMC revenue for 2025-12-31 was $26.98B. Net income was $4.16B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
AXSM currently screens at market cap $11.96B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the AXSM and MMC stock pages for the full models.
Not investment advice.